Interethnic differences in the prevalence of main cardiovascular pharmacogenetic biomarkers-Reference-Cited by-同舟云学术

Interethnic differences in the prevalence of main cardiovascular pharmacogenetic biomarkers

Published:2020-07 Issue:10 Volume:21 Page:677-694
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Mirzaev Karin¹,Abdullaev Sherzod¹,Akmalova Kristina¹,Sozaeva Jeannette¹,Grishina Elena¹,Shuev Gregory¹,Bolieva Laura²,Sozaeva Mariam³,Zhuchkova Svetlana⁴,Gimaldinova Natalya⁵,Sidukova Elena⁶,Serebrova Svetlana⁷,Asoskova Anastasia¹,Shein Alexander⁸,Poptsova Maria⁸,Suleymanov Salavat⁹,Burashnikova Irina¹⁰,Shikaleva Anastasia¹⁰,Kachanova Anastasia¹,Fedorinov Denis¹^ORCID,Sychev Dmitry¹

Affiliation:

1. Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of The Ministry of Healthcare of The Russian Federation, Barrikadnaya Str., 2/1, Bldg. 1, Moscow, 125993, Russian Federation

2. Federal State Budgetary Educational Institution of Higher Education “North Ossetia State Medical Academy” of The Ministry of Healthcare of the Russian Federation, Pushkinskaya Str., 40, Vladikavkaz, Republic of North Ossetia–Alania, 362019, Russian Federation

3. State Budgetary Healthcare Institution “Republican Clinical Hospital” of The Ministry of Healthcare of The Russian Federation, Nogmova Str., 91, Nalchik, Kabardino–Balkarian Republic, 360003, Russian Federation

4. Autonomous Institution “Republican Clinical Oncology Center” of the Ministry of Health of The Chuvash Republic, Gladkov Str., 31, Cheboksary, Chuvash Republic, 428020, Russian Federation

5. Federal State Budgetary Educational Institution of Higher Education “I. N. Ulianov Chuvash State University”, Moskovskiy Pr., 15, Cheboksary, Chuvash Republic, 428015, Russian Federation

6. State Budgetary Institution of The Republic of Mari El ‘Kozmodemyansk interdistrict hospital”, 3rd microdistrict, 25, Kozmodemyansk, Republic of Mari El, 425350, Russian Federation

7. Department of Clinical Pharmacology & Propaedeutic of Internal Diseases of The Faculty of General Medicine of Sechenov First Moscow State Medical University of The Ministry of Health of The Russian Federation, Trubetskaya Str., 8, bld., Moscow, 2119991, Russian Federation

8. Laboratory of Bioinformatics, Big Data & Information Retrieval School, Faculty of Computer Science, National Research University Higher School of Economics, 3 Kochnovsky Proezd, Moscow, 109028, Russian Federation

9. Russian–Japanese Medical Center “SAIKO”, Komsomolskaya St., 104, Khabarovsk, Khabarovsk Territory, 680000, Russian Federation

10. Kazan State Medical Academy, Kazan State Medical University, Mushtari st., 11, Kazan, Republic of Tatarstan, 420012, Russian Federation

Abstract

Background: The aim of this study was to determine the prevalence of CYP2C9, VKORC1, CYP2C19, ABCB1, CYP2D6 and SLCO1B1 genes polymorphisms among residents of the Volga region (Chuvash and Mari) and northern Caucasus (Kabardins and Ossetians). Materials & methods: The study involved 845 apparently healthy volunteers of both sexes of the four different ethnic groups living in the Russian Federation: 238 from the Chuvash ethnic group, 206 Mari, 157 Kabardins and 244 Ossetians. Results: Significant differences were identified in allele frequency of CYP2C9, VKORC1, CYP2C19, ABCB1, CYP2D6 and SLCO1B1 genes polymorphisms between the Chuvash and Kabardins, Chuvash and Ossetians, Mari and Kabardians, Mari and Ossetians.

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2020-0005

Reference64 articles.

1. Emergency Hospitalizations for Adverse Drug Events in Older Americans

2. Center for Drug Evaluation and Research. Genomics – table of pharmacogenomic biomarkers in drug labeling. https://www.fda.gov/downloads/Drugs/ScienceResearch/UCM578588.pdf

3. European Medicines Agency 2007. ICH E15 Definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics, genomic data and sample coding categories. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e-15-establish-definitions-genomic-biomarkers-pharmacogenomics-pharmacogenetics-genomic-data_en.pdf

4. Working Group. Methods|EGAPP|CDC. (2020). https://www.cdc.gov/egappreviews/methods.html

5. Pharmacogenetics in Cardiovascular Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Polymorphic Loci and Detection Methods for Two Important Hypertension Individualized Medication-Related Genes;Hans Journal of Biomedicine;2024

2. Ethnic Diversity and Warfarin Pharmacogenomics;Frontiers in Pharmacology;2022-04-04

3. Structure of the distribution of genetic determinants of the efficacy and safety of non-steroidal anti-inflammatory drugs in the Russian population: focus on CYP2C8, PTGS1 and PTGS2;Modern Rheumatology Journal;2022-02-19

4. Comprehensive Statistical and Bioinformatics Analysis in the Deciphering of Putative Mechanisms by Which Lipid-Associated GWAS Loci Contribute to Coronary Artery Disease;Biomedicines;2022-01-25

5. Contraindications Differ Widely Among Beta Blockers and Ought to be Cited for an Individual Drug, Not for the Entire Class;Current Pharmaceutical Design;2021-11-10